CRN adds new board members
WASHINGTON The Council for Responsible Nutrition last week announced that the following executives have been elected to serve on the CRN board of directors, effective January — Chuck Brice of Kemin Health; Larry Esposito of Innophos; Ron Fugate of Alacer Corporation; Scott Hagerman of Chemi Nutra; Carl Hastings of Reliv International; and Vic Neufeld of Jamieson Laboratories.
In addition, Jim Hamilton of DSM Nutritional Products has been named CRN’s new chair-elect, replacing Janice Binger, formerly of Archer Daniels Midland.
“This has been a year of change for the dietary supplement industry, particularly with the shift of power in Washington,” stated Mark LeDoux, CRN chair. “Similarly the coming year will bring many challenges, but with those challenges comes the prospect of great opportunity. CRN’s board of directors will strategically lead CRN to meet those challenges and pursue those opportunities both here and abroad.”
Following is a list of CRN’s board of directors, including Officers, for 2010:
- Natalie Bartner, Pfizer Consumer Healthcare;
- John Blair, NSA;
- Kristen Blanchard, Nutramax Laboratories (secretary);
- Paul Bolar, Pharmavite;
- Michael Bradley, Perrigo Co.;
- Chuck Brice, Kemin Health;
- David Christensen, Bayer Healthcare (treasurer);
- Greg Dodson, Archer Daniels Midland;
- Larry Esposito, Innophos;
- Marjorie Fine, Shaklee Corp.;
- Ron Fugate, Alacer Corp.;
- Scott Hagerman, Chemi Nutra;
- Jim Hamilton, DSM Nutritional Products (chair-elect);
- Carl Hastings, Reliv International;
- David Henstrom, Cargill Health & Nutrition;
- Byron Johnson, Amway Corp.;
- Harvey Kamil, NBTY;
- Mark LeDoux, Natural Alternatives International (chair);
- Doug Lioon, Douglas Laboratories;
- Kathy McKnight, Natural Factors Nutritional Products;
- Raj Mishra, GlaxoSmithKline;
- Steve Mister, CRN (president & CEO);
- David Morrison, The Vitamin Shoppe;
- Vic Neufeld, Jamieson Laboratories;
- Ona Scandurra, Country Life Vitamins;
- Nick Shackley, BASF Corp.;
- Robert Sinott, Mannatech;
- Don Stanek, Linnea;
- David Sullivan, GNC;
- Bill Van Dyke, B&D Nutritional Ingredients;
- John Venardos, Herbalife International of America;
- Tyler Whitehead, NuSkin Enterprises; and
- Bruce Wood, Schiff Nutrition International.
Sanofi-Aventis to acquire OTC maker Chattem
PARIS Sanofi-Aventis will acquire a manufacturer of OTC drugs, dietary supplements and toiletries, the French drug maker announced Monday.
Sanofi said it had made an agreement with Chattanooga, Tenn.-based Chattem to acquire the company for $1.9 billion, or $93.50 per share. Chattem, founded 130 years ago, manufactures brands such as Selsun Blue, Cortizone-10 and Icy Hot. Sanofi said the deal would create the world’s fifth largest consumer healthcare company.
“The acquisition of Chattem will be a significant milestone in Sanofi-Aventis’ transformation strategy and will provide us with the ideal platform in the U.S. consumer healthcare market, which represents 25% of the current worldwide opportunity,” Sanofi CEO Christopher Viehbacher said in a statement. “In addition, we believe our abilityt o convert prescription medicines to OTC products will be enhanced by Chattem’s leading sales, marketing and distribution channels.”
Pharmavite CEO to step down
NORTHRIDGE Connie Barry, Pharmavite president and CEO since 2005, on Friday announced that she will be stepping down from her role at the company effective Jan. 31, 2010, due to personal health issues.
Barry is a 30-year Pharmavite veteran who led the company through its largest growth period. Under her leadership, Nature Made, Pharmavite’s flagship supplement brand, significantly grew market share, expanded distribution and maintained its position as the No. 1 selling brand in the food, drug, mass and club channels.
Pharmavite’s Board is expected to name a successor in the next few weeks. In the interim, the current executive team will continue to lead the company. Barry has agreed to continue in an advisory capacity as needed to support the organization.